Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: ADAPTIVE BIOTECHNOLOGIES CORPORATION
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2025-03-14 to 2026-03-13
Current total value of award: $117000
Description: CLONOSEQ FDA-CLEARED IN VITRO DIAGNOSTIC (IVD) TESTING SERVICES